Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Precigen, Inc. Common Stock (PGEN)

Pharmaceutical Preparations

http://www.precigen.com

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

20374 SENECA MEADOWS PARKWAY
GERMANTOWN, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/08/2013

Market Cap

313,608,260

Shares Outstanding

248,920,000

Weighted SO

248,919,093

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

CRMD --.--%

TCRR --.--%

SGMO --.--%

APTO --.--%

SELB --.--%

PRTK --.--%

CRVS --.--%

IMMP --.--%

ICVX --.--%

Beta

1.7250

Last Div

0.0000

Range

0.84-1.93

Chg

0.0200

Avg Vol

1079027

Mkt Cap

313608260

Exch

NASDAQ

Country

US

Phone

301 556 9900

DCF Diff

1.1337

DCF

-0.0536

Div Yield

0.0000

P/S

15.8934

EV Multiple

-4.0371

P/FV

6.3720

Div Yield %

0.0000

P/E

-9.7522

PEG

-3.9009

Payout

0.0000

Current Ratio

1.0301

Quick Ratio

1.0301

Cash Ratio

0.4059

DSO

18.7938

DIO

0.0000

Op Cycle

18.7938

DPO

215.6666

CCC

-196.8728

Gross Margin

0.5844

Op Margin

-4.1426

Pretax Margin

-6.3516

Net Margin

-1.4295

Eff Tax Rate

0.7749

ROA

-0.3856

ROE

-0.2777

ROCE

-1.6304

NI/EBT

0.2251

EBT/EBIT

1.5332

EBIT/Rev

-4.1426

Debt Ratio

0.0867

D/E

0.1469

LT Debt/Cap

0.1051

Total Debt/Cap

0.1281

Int Coverage

-10217.7500

CF/Debt

-11.0347

Equity Multi

1.6947

Rec Turnover

19.4213

Pay Turnover

1.6924

Inv Turnover

0.0000

FA Turnover

1.0385

Asset Turnover

0.2697

OCF/Share

-0.2773

FCF/Share

-0.3088

Cash/Share

0.0774

OCF/Sales

-3.5461

FCF/OCF

1.1137

CF Coverage

-11.0347

ST Coverage

-55.1387

CapEx Coverage

-8.7959

Div&CapEx Cov

-8.7959

P/BV

6.3720

P/B

6.3720

P/S

15.8934

P/E

-9.7522

P/FCF

-4.0244

P/OCF

-3.9313

P/CF

-3.9313

PEG

-3.9009

P/S

15.8934

EV Multiple

-4.0371

P/FV

6.3720

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation